Regulations.gov document
Decision of the Commissioner re Proposal to Withdraw Approval for the Breast Cancer…
Other · FDA-2010-N-0621 · posted Nov 21, 2011
Key facts
| Document ID | FDA-2010-N-0621-0544 |
|---|---|
| Title | Decision of the Commissioner re Proposal to Withdraw Approval for the Breast Cancer Indication for Bevacizumab (Avastin) November 18, 2011 - Commissioner's Decision |
| Document type | Other |
| Subtype | Commissioners Decision |
| Agency | FDA |
| Docket | FDA-2010-N-0621 |
| Posted | Nov 21, 2011 |
| Comment period opens | Nov 21, 2011 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: